RESUMO
Cutis laxa is a rare connective tissue disorder, characterized by a reduced number and abnormal properties of elastic fibers throughout the dermis, creating a clinical appearance of premature aging. It can be subdivided into inherited and acquired, the latter rarer than the former, and skin involvement may be localized or generalized. The etiology of acquired cutis laxa (ACL) remains unknown and there is no definitive treatment. We present the case of a 30-year-old man diagnosed with type I ACL with progressive systemic involvement at the renal, pulmonary, and digestive levels. Histological analysis of the skin revealed reduction and fragmentation of elastic fibers. Immunosuppressive treatment was started with prednisone, cyclophosphamide, and rituximab, with which a complete response to proteinuria was achieved and the progression of lung damage was limited. Autoimmune, infectious, and neoplastic diseases were ruled out.
Assuntos
Cútis Laxa , Masculino , Humanos , Adulto , Cútis Laxa/diagnóstico , Cútis Laxa/tratamento farmacológico , Cútis Laxa/patologia , Pele/patologia , Imunossupressores , Ciclofosfamida/uso terapêutico , RituximabRESUMO
BACKGROUND: Traditional facelift surgery does not behave well in the correction of nasolabial folds, which is a common clinical problem and needed to be improved. OBJECTIVES: To investigate the effect of free dermal fat grafting during facelift surgery for the treatment of nasolabial folds. METHODS: This prospective cohort study involved 80 patients with moderate to severe nasolabial folds and facial skin dermatolysis. Fifty of them underwent facelift surgery combined with free dermal fat grafting, and 30 of them underwent traditional facelift surgery. These patients were followed up 2 months, 6 months, and 1 year after the surgery to evaluate the effect. RESULTS: The difference in Wrinkle Severity Rating Scale (WSRS) scores, assessed at each follow-up, between the patients who underwent and did not undergo free dermal fat grafting during facelift surgery, was statistically significant. For patients who underwent free dermal fat grafting during facelift surgery, the WSRS scores assessed at 2 months, 6 months, and 1 year after the surgery were significantly different from those before the surgery. The analytic results of FACE-Q indicated a high level of overall satisfaction rate. No major complications were recorded. CONCLUSIONS: Free dermal fat as a filler for nasolabial folds can achieve excellent therapeutic effect. The combination of facelift surgery with free dermal fat grafting for the treatment of nasolabial folds can provide very good long-term results and a high patient satisfaction rate for patients with symptoms of facial aging such as facial dermatolysis, obvious wrinkles, and deep nasolabial folds.
Assuntos
Técnicas Cosméticas , Cútis Laxa , Preenchedores Dérmicos , Ritidoplastia , Envelhecimento da Pele , Humanos , Ritidoplastia/efeitos adversos , Ritidoplastia/métodos , Sulco Nasogeniano/cirurgia , Estudos Prospectivos , Cútis Laxa/tratamento farmacológico , Ácido Hialurônico/uso terapêutico , Tecido Adiposo , Resultado do TratamentoAssuntos
Cútis Laxa/diagnóstico , Derme/patologia , Granuloma Anular/diagnóstico , Adulto , Doenças Assintomáticas/terapia , Betametasona/administração & dosagem , Betametasona/análogos & derivados , Biópsia , Cútis Laxa/tratamento farmacológico , Cútis Laxa/etiologia , Cútis Laxa/patologia , Feminino , Granuloma Anular/complicações , Granuloma Anular/tratamento farmacológico , Granuloma Anular/patologia , Humanos , Creme para a Pele/administração & dosagem , Resultado do Tratamento , Tretinoína/administração & dosagemRESUMO
Sweet syndrome is rare in the pediatric population and usually responds well to treatment, resolving without sequelae. Marshall syndrome is a rare pediatric skin disease characterized by loss of elastic tissue (cutis laxa) secondary to acquired, localized neutrophilic dermatitis without any internal organ involvement. Only few cases of Marshall syndrome (acquired cutis laxa type II) have been reported. Systemic steroids and dapsone show excellent results in Sweet syndrome. Although there is no satisfactory treatment for cutis laxa, dapsone can be used in the acute phase for control of swelling.
Assuntos
Catarata/tratamento farmacológico , Colágeno Tipo XI/deficiência , Anormalidades Craniofaciais/tratamento farmacológico , Cútis Laxa , Dapsona/administração & dosagem , Perda Auditiva Neurossensorial/tratamento farmacológico , Osteocondrodisplasias/tratamento farmacológico , Síndrome de Sweet , Catarata/metabolismo , Catarata/patologia , Pré-Escolar , Colágeno Tipo XI/metabolismo , Anormalidades Craniofaciais/metabolismo , Anormalidades Craniofaciais/patologia , Cútis Laxa/tratamento farmacológico , Cútis Laxa/metabolismo , Cútis Laxa/patologia , Feminino , Perda Auditiva Neurossensorial/metabolismo , Perda Auditiva Neurossensorial/patologia , Humanos , Osteocondrodisplasias/metabolismo , Osteocondrodisplasias/patologia , Síndrome de Sweet/tratamento farmacológico , Síndrome de Sweet/metabolismo , Síndrome de Sweet/patologiaRESUMO
Marshall's syndrome is a form of acquired cutis laxa without systemic involvement, which is preceded by an inflammatory dermatitis with a neutrophilic component. We report a case of a 6-year-old boy with clinical and histopathological features of this syndrome. The etiology remains unknown and there is no definitive treatment.
Assuntos
Cútis Laxa/patologia , Biópsia , Criança , Cútis Laxa/tratamento farmacológico , Humanos , Masculino , Pele/patologia , Síndrome , Resultado do TratamentoRESUMO
Marshall´s syndrome is a form of acquired cutis laxa without systemic involvement, which is preceded by an inflammatory dermatitis with a neutrophilic component. We report a case of a 6-year-old boy with clinical and histopathological features of this syndrome. The etiology remains unknown and there is no definitive treatment.
Síndrome de Marshall é uma forma de cutis laxa adquirida, sem envolvimento sistêmico, que é precedida por uma dermatite inflamatória com componente neutrofílico. Relatamos o caso de um menino de 6 anos de idade com as características clínicas e histopatológicas desta síndrome. A etiologia desta doença permanece desconhecida e ainda não existe um tratamento definitivo. .
Assuntos
Criança , Humanos , Masculino , Cútis Laxa/patologia , Biópsia , Cútis Laxa/tratamento farmacológico , Síndrome , Pele/patologia , Resultado do TratamentoAssuntos
Autoimunidade , Cútis Laxa/imunologia , Tecido Elástico/imunologia , Pele/imunologia , Adulto , Anticorpos Antinucleares/sangue , Anticorpos Antifosfolipídeos/sangue , Biópsia , Cútis Laxa/sangue , Cútis Laxa/tratamento farmacológico , Cútis Laxa/patologia , Fármacos Dermatológicos/uso terapêutico , Tecido Elástico/efeitos dos fármacos , Tecido Elástico/patologia , Feminino , Humanos , Hidroxicloroquina/uso terapêutico , Ilhotas Pancreáticas/imunologia , Pele/efeitos dos fármacos , Pele/patologia , Resultado do TratamentoRESUMO
Blepharochalasis is characterized by recurrent painless oedema of the eyelids leading to alteration of periorbital skin with a nearly complete loss of elastic fibers. It usually affects the upper eyelids bilaterally. An 11-year-old girl suffered from recurrent erythematous swelling episodes during 3 months. The manifestations were confined to the periorbital region. She gradually noticed a bilateral loss of elasticity of the skin of the upper eyelid. The skin showed some folding and laxity. A mild aponeurotic ptosis was present. A skin biopsy showed the absence of elastic fibres. Blepharochalasis is a disease of young people. It has been divided in two hypertrophic and atrophic types. The condition typically follows recurrent painless episodes of oedema infiltrating both upper eyelids. The eyelid oedema usually resolves after several days and recures several times a year.
Assuntos
Cútis Laxa/diagnóstico , Doenças Palpebrais/diagnóstico , Pálpebras/patologia , Blefaroptose , Criança , Cútis Laxa/tratamento farmacológico , Cútis Laxa/cirurgia , Diagnóstico Diferencial , Quimioterapia Combinada , Edema/patologia , Doenças Palpebrais/tratamento farmacológico , Doenças Palpebrais/cirurgia , Pálpebras/cirurgia , Feminino , Glucocorticoides/uso terapêutico , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , HumanosRESUMO
INTRODUCTION: Cutis laxa is a rare disorder characterized by loss of elastic tissue. Several organs are often involved such as the skin, lungs, heart, digestive system or genitourinary tract. It may be inherited or acquired, generalized or localized. Its pathogenesis is unclear. Association of acquired cutis laxa with myeloma or plasma cell dyscrasia is very rare. We report a case of acquired cutis laxa associated with a myeloma. CASE REPORT: A 59 year-old woman was admitted for skin hyperlaxity present for a number of years. Light microscopic examination of a skin sample revealed fragmented elastic fibers. Electron microscopic examination of the elastic network demonstrated numerous large vacuolated cells with the appearance of macrophages around abnormal elastic and collagen fibers of the reticular dermis. In addition, a stage-1 IgG lambda myeloma was detected. The patient was treated by thalidomide for one year. After this treatment, electron microscopy examination did not reveal any large vacuolated cells in the dermis, and elastic and collagen fibers were not modified and skin laxity seemed to be stabilized. DISCUSSION: Acquired cutis laxa may be associated with many systemic diseases or can appear after inflammatory skin diseases. Seven cases of generalized cutis laxa associated with myeloma and four cases associated with plasma cell dyscrasia have been reported in the literature. In our case, as in 2 previously described cases, large vacuolated cells resembling macrophages were seen in the dermis. They were thought to play a role in cutis laxa.
Assuntos
Cútis Laxa/patologia , Derme/patologia , Mieloma Múltiplo/patologia , Cútis Laxa/complicações , Cútis Laxa/tratamento farmacológico , Feminino , Humanos , Imunossupressores/uso terapêutico , Pessoa de Meia-Idade , Mieloma Múltiplo/complicações , Mieloma Múltiplo/tratamento farmacológico , Talidomida/uso terapêutico , Resultado do TratamentoRESUMO
BACKGROUND: Cutis laxa is characterized by the total loss of skin elasticity, which is also called generalized elastosis that leads to the appearance of early aging. OBJECTIVE: The authors report a patient with cutis laxa in which botulinum toxin was used for the improvement of facial aesthetics. This is a case report with a literature review. Botulinum toxin was injected into the classical sites usually used for the treatment of dynamic wrinkles. RESULTS: The patient showed improvement of the aging appearance. CONCLUSION: The use of botulinum toxin may represent an additional, less invasive resource to improve facial defects in these patients.
Assuntos
Toxinas Botulínicas/uso terapêutico , Cútis Laxa/diagnóstico , Cútis Laxa/tratamento farmacológico , Dermatoses Faciais/diagnóstico , Dermatoses Faciais/tratamento farmacológico , Fármacos Neuromusculares/uso terapêutico , Adolescente , Toxinas Botulínicas/administração & dosagem , Cútis Laxa/patologia , Diagnóstico Diferencial , Dermatoses Faciais/patologia , Feminino , Humanos , Injeções Intradérmicas , Fármacos Neuromusculares/administração & dosagemRESUMO
Idiopathic middermal elastolysis (IMDE) is a rare disorder with two different clinical presentations: type I lesions, with tiny wrinkles along skin cleavage lines in large confluent areas, and type II lesions, with small perifollicular papular protrusions. The histopathological picture is characteristic. IMDE is mainly seen in healthy young or middle-aged women. We describe a 60-year-old male patient with this disorder. The special interest of this case report is that there was no photosensitivity and no exacerbation with PUV therapy. IMDE is probably a special sort of elastolytic disorder, for which immunologic mechanisms seem possible.